Detalhe da pesquisa
1.
Novel chimeric antigen receptor-expressing T cells targeting the malignant mesothelioma-specific antigen sialylated HEG1.
Int J Cancer;
154(10): 1828-1841, 2024 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38212893
2.
Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.
Cancer Immunol Immunother;
72(8): 2829-2840, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37188764
3.
Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation.
Comput Struct Biotechnol J;
23: 859-869, 2024 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38356658
4.
Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors.
Front Cell Dev Biol;
11: 1324898, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38469154
5.
Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures.
J Immunother Cancer;
11(7)2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37433717